Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Malaria Journal
|
May 19, 2016
Pre-clinical evaluation of CYP 2D6 dependent drug-drug interactions between primaquine and SSRI/SNRI antidepressants
Xiannu Jin, Brittney Potter, Thu-Lan Luong, et al.
Plos One
|
December 28, 2018
The use of Fionet technology for external quality control of malaria rapid diagnostic tests and monitoring health workers' performance in rural military health facilities in Tanzania
Akili K Kalinga, Deus S Ishengoma, Reginald Kavishe, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
February 9, 2012
Ketotifen is an antimalarial prodrug of norketotifen with blood schizonticidal and liver-stage efficacy
Erin Milner, Jason Sousa, Brandon Pybus, et al.
Malaria Journal
|
January 7, 2014
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
Sean R Marcsisin, Jason C Sousa, Gregory A Reichard, et al.
Malaria Journal
|
May 31, 2018
Comparison of visual and automated Deki Reader interpretation of malaria rapid diagnostic tests in rural Tanzanian military health facilities
Akili K Kalinga, Charles Mwanziva, Sarah Chiduo, et al.
Nucleic Acids Research
|
May 13, 2022
The Quest for Orthologs orthology benchmark service in 2022
Yannis Nevers, Tamsin E M Jones, Dushyanth Jyothi, et al.
Iscience
|
January 11, 2024
From <i>Tg</i>O/GABA-AT, GABA, and T-263 Mutant to Conception of <i>Toxoplasma</i>
Joseph Lykins, Matthew J Moschitto, Ying Zhou, et al.
Scientific Reports
|
July 15, 2016
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections
Martin McPhillie, Ying Zhou, Kamal El Bissati, et al.
Scientific Reports
|
April 7, 2020
Author Correction: New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections
Martin McPhillie, Ying Zhou, Kamal El Bissati, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Malaria Journal
|
May 19, 2016
Pre-clinical evaluation of CYP 2D6 dependent drug-drug interactions between primaquine and SSRI/SNRI antidepressants
Xiannu Jin, Brittney Potter, Thu-Lan Luong, et al.
Plos One
|
December 28, 2018
The use of Fionet technology for external quality control of malaria rapid diagnostic tests and monitoring health workers' performance in rural military health facilities in Tanzania
Akili K Kalinga, Deus S Ishengoma, Reginald Kavishe, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
February 9, 2012
Ketotifen is an antimalarial prodrug of norketotifen with blood schizonticidal and liver-stage efficacy
Erin Milner, Jason Sousa, Brandon Pybus, et al.
Malaria Journal
|
January 7, 2014
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
Sean R Marcsisin, Jason C Sousa, Gregory A Reichard, et al.
Malaria Journal
|
May 31, 2018
Comparison of visual and automated Deki Reader interpretation of malaria rapid diagnostic tests in rural Tanzanian military health facilities
Akili K Kalinga, Charles Mwanziva, Sarah Chiduo, et al.
Nucleic Acids Research
|
May 13, 2022
The Quest for Orthologs orthology benchmark service in 2022
Yannis Nevers, Tamsin E M Jones, Dushyanth Jyothi, et al.
Iscience
|
January 11, 2024
From <i>Tg</i>O/GABA-AT, GABA, and T-263 Mutant to Conception of <i>Toxoplasma</i>
Joseph Lykins, Matthew J Moschitto, Ying Zhou, et al.
Scientific Reports
|
July 15, 2016
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections
Martin McPhillie, Ying Zhou, Kamal El Bissati, et al.
Scientific Reports
|
April 7, 2020
Author Correction: New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections
Martin McPhillie, Ying Zhou, Kamal El Bissati, et al.
Page
of 3